Skip to main content
Michael Baine, MD, Radiation Oncology, Omaha, NE, The Nebraska Medical Center

MichaelJamesBaineMDPhD

Radiation Oncology Omaha, NE

Urologic Cancer

Assistant Professor

Dr. Baine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Baine's full profile

Already have an account?

Summary

  • I am a member of the Department of Radiation Oncology at the University of Nebraska Medical Center, acting in a physician scientist role. My clinical practice is focused on GU malignancies with my lab investigating pancreas, prostate, and bladder cancers. I have specific interests in radiomics, ultrahypofractionated radiation treatment for prostate, body SBRT for oligometastatic diseases, and the interactions between high dose-per-fraction radiation treatments and the immune system with the hope of leveraging this into greater efficacy of immunotherapy.

Education & Training

  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineResidency, Radiation Oncology, 2015 - 2019
  • University of Nebraska Medical Center College of Medicine
    University of Nebraska Medical Center College of MedicineInternship, Internal Medicine, 2014 - 2015
  • University of Nebraska College of Medicine
    University of Nebraska College of Medicine

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2019 - 2024
  • IA State Medical License
    IA State Medical License 2019 - 2024
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Sigma Xi 2022
  • Alpha Sigma Nu Loyola Marymount University, 2006
  • Inductee Alpha Omega Alpha Honor Medical Society

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Impact of Neoadjuvant and Adjuvant Immunotherapy on the Survival of Pancreatic Cancer Patients: A Retrospective Analysis
    The Impact of Neoadjuvant and Adjuvant Immunotherapy on the Survival of Pancreatic Cancer Patients: A Retrospective AnalysisJune 9th, 2020
  • The Impact of Immunotherapy on the Survival of Pancreatic Adenocarcinoma Patients Who Received Definitive Surgery of the Pancreatic Tumor: A Retrospective Analysis of the National Cancer Database
    The Impact of Immunotherapy on the Survival of Pancreatic Adenocarcinoma Patients Who Received Definitive Surgery of the Pancreatic Tumor: A Retrospective Analysis of the National Cancer DatabaseJune 3rd, 2020

Professional Memberships

Hospital Affiliations